Neuraxpharm owns and operates Neuraxpharm Pharmaceuticals, a global manufacturing company based in Spain. It employs more than 300 people developing and manufacturing finished dosage forms (FDFs) in mainly solid oral dosage forms for the Group and for other national and global pharmaceutical companies. We also offers a full manufacturing service for customised FDF pharmaceuticals, based upon our own developments
Here you can find out more about out Non-Financial Information Statement
Neuraxpharm Pharmaceuticals plant specialises in the development and manufacturing of oral solid and sterile forms, mainly in the CNS area. Its portfolio also includes antiemetic, anti-infective, cardiovascular, pain and respiratory products.
Neuraxpharm Pharmaceuticals highly flexible approach and extensive experience have enabled it to cement its place as a reliable partner for large national and international third-party laboratories.
It offers contract manufacturing services for fast dissolving (orodispersible) tablets, using lyophilization techniques.
The company has around 200 employees with teams focused on quality control, materials technology, contract manufacturing, quality assurance, engineering, logistics, safety and environment, and production.
Neuraxpharm Pharmaceuticals has a long history of successfully developing dossiers of generic and specialised pharmaceuticals that meet the latest high regulatory standards. Those dossiers can be licensed from Neuraxpharm Pharmaceuticals, including FDFs with customised artwork designed for specific market needs.
Neuraxpharm Pharmaceuticals has international authorisation for tablets, capsules, powders and injectables.
Successful internal/external audits
High regulatory performance
More than 125 granted patents in the most important countries worldwide
More than 220 dossiers (FDF) submitted to regulatory agencies of different territories
Join our mailing list
Get the latest updates from the Neuraxpharm.